2012
Physical therapy interventions for knee pain secondary to osteoarthritis: a systematic review.
Wang SY, Olson-Kellogg B, Shamliyan TA, Choi JY, Ramakrishnan R, Kane RL. Physical therapy interventions for knee pain secondary to osteoarthritis: a systematic review. Annals Of Internal Medicine 2012, 157: 632-44. PMID: 23128863, DOI: 10.7326/0003-4819-157-9-201211060-00007.Peer-Reviewed Original ResearchConceptsLow-strength evidencePhysical therapy interventionsPT interventionsIndividual RCTsAerobic exerciseTherapy interventionPool standardized mean differencesPhysiotherapy Evidence DatabaseRisk of biasCommunity-dwelling adultsStandardized mean differenceMeans of outcomesImproved disabilityKnee painAdverse eventsKnee osteoarthritisNonsurgical treatmentCochrane LibraryPhysical functionEvidence DatabaseLeading causeOutcome measuresSustained benefitPainSynthesis of evidence
2010
Association Between Patient and Tumor Characteristics With Clinical Outcomes in Women With Ductal Carcinoma In Situ
Shamliyan T, Wang SY, Virnig BA, Tuttle TM, Kane RL. Association Between Patient and Tumor Characteristics With Clinical Outcomes in Women With Ductal Carcinoma In Situ. JNCI Monographs 2010, 2010: 121-129. PMID: 20956815, PMCID: PMC5161074, DOI: 10.1093/jncimonographs/lgq034.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAgedBody Mass IndexBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingFemaleGonadal Steroid HormonesHumansMammographyMenopauseNeoplasm Recurrence, LocalNeoplasms, Hormone-DependentPrognosisRacial GroupsRandomized Controlled Trials as TopicReceptor, ErbB-2Receptors, EstrogenReceptors, ProgesteroneRiskSocioeconomic FactorsTreatment OutcomeTumor BurdenConceptsDuctal carcinomaClinical outcomesRecurrent cancerTumor characteristicsWorse outcomesNegative estrogen receptor statusAdvanced recurrent cancerPositive surgical marginsEstrogen receptor statusLarger tumor sizeHigh-risk categoryComposite prognostic indicesReceptor statusSurgical marginsPrognostic indexTumor sizeComedo necrosisPathological gradingClinical trialsObservational studyHigh riskHER2 receptorSynthesis of evidenceHigh mortalityYoung women